Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma

Journal of Clinical Pathology

Volumn 65, Issue 9, 2012, Pages 802-807

  Liang, Peir In ^a   Wu, Li Ching ^a   Sheu, Jim Jinn Chyuan ^b,c   Wu, Ting Feng ^d   Shen, Kun Hung ^a   Wang, Yu Hui ^e   Wu, Wen Ren ^f   Shiue, Yow Ling ^f   Huang, Hsuan Ying ^g   Hsu, Han Ping ^h   Chen, Yi Hsien ^a   Chen, Li Tzon ⁱ   Li, Chien Feng ^a,d,f,i   Liao, Alex C ^a,j  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^f NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^g CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^h CHINA MEDICAL UNIVERSITY   (Taiwan)

ⁱ NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^j CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RSF 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; MITOSIS; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84866094844     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-200897     Document Type: Article

References (20)

1. Eble JN, Sauter G, Epstein JI, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: International Agency for Research on Cancer (IARC) press, 2004:93-109.
2. Hall RR, Parmar MK, Richards AB, et al. Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy. Br Med J 1994;308:257-60.
3. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual . 7th edn. New York, NY: Springer, 2010:497-505.
4. Roberts CW, Orkin SH. The SWI/SNF complexechromatin and cancer. Nat Rev Cancer 2004;4:133-42.
5. Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol Med 2007;13:373-80.
6. Wolffe AP. Chromatin remodeling: why it is important in cancer. Oncogene 2001;20:2988-90.
7. Loyola A, Huang JY, LeRoy G, et al. Functional analysis of the subunits of the chromatin assembly factor RSF. Mol Cell Biol 2003;23:6759-68.
8. Shamay M, Barak O, Shaul Y. HBXAP, a novel PHD-finger protein, possesses transcription repression activity. Genomics 2002;79:523-9.
9. Shih IM, Sheu JJ, Santillan A, et al. Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. Proc Natl Acad Sci USA 2005;102:14004-9.
10. Schwab M. Amplification of oncogenes in human cancer cells. Bioessays 1998;20:473-9.
11. Fang FM, Li CF, Huang HY, et al. Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma. Am J Pathol 2011;178:2407-15.
12. Chen TJ, Huang SC, Huang HY, et al. Rsf-1/HBXAP overexpression is associated with disease-specific survival of patients with gallbladder carcinoma. APMIS 2011;119:808-14.
13. Hui AB, Or YY, Takano H, et al. Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Cancer Res 2005;65:8125-33.
14. Choi JH, Sheu JJ B, Guan B, et al. Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer. Cancer Res 2009;69:1407-15.
15. Sehdev AS, Kurman RJ, Kuhn E, et al . Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase. Mod Pathol 2010;23:844-55.
16. Zaharieva BM, Simon R, Diener PA, et al. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 2003;201:603-8.
17. Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, et al. Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol 2010;28:401-8.
18. Goeball PJ, Groshen SG, Schmitz-Dräger BJ. p53 immunohistochemistry in bladder cancer - a new approach to an old question. Urol Oncol 2010;28:377-88.
19. Sheu JJ, Guan B, Choi JH, et al. Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability. J Biol Chem 2010;285:38260-9.
20. Tai HC, Huang HY, Lee SW, et al. Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma. J Clin Pathol 2012;65:248-53.